RGT 3.51% 29.5¢ argent biopharma limited

Ann: MGC License Approvals Set to Fast Track Commercialisation, page-2

  1. 15,073 Posts.
    lightbulb Created with Sketch. 560
    Just in case you missed the detail of this announcement:​

    MGC Pharmaceuticals (MGC) granted key commercial licenses to grow, process, import and export Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin in Slovenia, Europe
    • MGC becomes the first ASX related vehicle to be granted a Cannabis
    Sativa L (Hemp) growing license and licences to sell CBD resin into the European Union (EU)
    • First company in Slovenia to have a license to extract CBD resin on site and sell direct into EU
    • Facilitates immediate commencement of operations in Slovenia, with initial production and extraction of CBD resin from crops now expected in late 2015
    • Approval of licenses fast tracks MGC’s commercialisation and business model– cashflow breakeven now expected within 12 months and revenues in excess of US$10m expected from the first year of full production in Slovenia, CY2017
    • Positions MGC to become an extraction facility for other growing operations in the region
    Negotiations significantly advanced for major off-take agreement with European distributor

    It's not like it won't happen or it's difficult to do...it's only a matter of time now!

    The signing of an off-take agreement should seal the deal for sceptical investors imo.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.